SEC Form 4 · accession 0001104659-15-013088
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Cook Jr.
Director
Period of report
Feb 19, 2015
Accepted (ET)
Feb 23, 2015 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Feb 19, 2015 | S | 32,900 | $15.60 | D | 49,175 | D | |
| Class A Common StockF3 | Feb 20, 2015 | S | 2,600 | $15.63 | D | 46,575 | D | |
| Class B Common Stock | holding | — | — | — | 306,163 | D | ||
| Class B Common StockF4 | holding | — | — | — | 24,000 | I | By Farview Management Company, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.55 to $15.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4The reporting person is a general partner of Farview Management Company, L.P., the beneficial owner of the securities.